がん研究のアーカイブ

  • ISSN: 2254-6081
  • ジャーナル h-index: 13
  • 雑誌引用スコア: 3.58
  • ジャーナルのインパクトファクター: 3.12
インデックス付き
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

An Introduction to Immunotherapy in the Treatment of Brain Tumors

Marry Joseph*

A relatively tiny portion of all malignancies in humans are brain cancers. The intricacy and importance of the brain's function, however, result in a high morbidity and death rate for malignancies of the brain. The cerebrospinal fluid and meninges surround the neurons, supporting or glial cells, cranial nerves, glands, and blood arteries that make up the human brain, which is enclosed in a solid skull vault. Each of these cellular components has the potential to become primary brain tumours with different subtypes and levels of aggressiveness. Secondary or metastatic brain malignancies are increasingly common as a result of better control of more common cancers such breast, lung, and colon. The biology of the malignancy is the primary determinant of the clinical consequences of a brain tumour. The tumor's location and its ability to receive treatment with little side effect come next. Size, vascularity, peri-tumoral edoema, and adverse effects of treatments on the nearby normal brain are other significant factors.

Keywords

Brain; Cancer; Health care; Neuroscience

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません